Stock Events

Stock Events

Novacyt 

€0.37
81
-€0-0.53% Today

Statistics

Day High
0.38
Day Low
0.37
52W High
0.74
52W Low
0.37
Volume
32,514
Avg. Volume
164,242
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23AprExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Next
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-207.19%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
48.5MRevenue
-100.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALNOV.PA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, competing directly with Novacyt's diagnostic solutions.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, overlapping with Novacyt's offerings.
Qiagen NV
QGEN
Mkt Cap8.46B
QIAGEN N.V. specializes in sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, directly competing with Novacyt's molecular diagnostic products.
Quest Diagnostics
DGX
Mkt Cap22.03B
Quest Diagnostics Incorporated offers diagnostic testing, information, and services, including COVID-19 testing, which competes with Novacyt's pandemic response products.
BioNTech
BNTX
Mkt Cap22.92B
BioNTech SE operates in the biotechnology and pharmaceutical fields, developing therapies and vaccines, including for COVID-19, which places it in competition with Novacyt's diagnostic solutions for the pandemic.
Hologic
HOLX
Mkt Cap16.89B
Hologic, Inc. specializes in diagnostics, medical imaging systems, and surgical products, especially for women’s health, competing in the diagnostics market alongside Novacyt.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including diagnostics that compete with Novacyt's portfolio.
Roche
RHHBY
Mkt Cap321.08B
Roche Holding AG focuses on pharmaceuticals and diagnostics. Its extensive diagnostics division directly competes with Novacyt in the field of infectious disease testing.
Danaher
DHR
Mkt Cap135.26B
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services, with a diagnostics segment that competes with Novacyt.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca PLC, while primarily known for pharmaceuticals, has been involved in developing COVID-19 vaccines and related diagnostics, positioning it as a competitor in the pandemic response market where Novacyt operates.

About

Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. It serves hospitals and corporates. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.
Show more...
CEO
Mr. Lyn Dafydd Rees
Employees
234
Country
FR
ISIN
FR0010397232

Listings

PA
FR
ALNOV.PA
F
DE
NYZ.F
LSE
GB
NCYT.LSE
OTC Link
US
NVYTF

0 Comments

Share your thoughts

FAQ

What is Novacyt stock price today?▼
The current price of ALNOV.PA is €0.37 EUR — it has decreased by -0.53% in the past 24 hours. Watch Novacyt stock price performance more closely on the chart.
What is Novacyt stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Novacyt stocks are traded under the ticker ALNOV.PA.
Is Novacyt stock price growing?▼
ALNOV.PA stock has risen by +0.4% compared to the previous week, the month change is a -2.98% fall, over the last year Novacyt has showed a -22.89% decrease.
When is the next Novacyt earnings date?▼
Novacyt is going to release the next earnings report on April 23, 2026.
What is Novacyt revenue for the last year?▼
Novacyt revenue for the last year amounts to 48.5M EUR.
What is Novacyt net income for the last year?▼
ALNOV.PA net income for the last year is -100.49M EUR.
How many employees does Novacyt have?▼
As of April 09, 2026, the company has 234 employees.
In which sector is Novacyt located?▼
Novacyt operates in the Health Care sector.
When did Novacyt complete a stock split?▼
Novacyt has not had any recent stock splits.
Where is Novacyt headquartered?▼
Novacyt is headquartered in Le Vésinet, FR.